| Asthenopia among university students: the eye of the digital generation RIT Sawaya, N El Meski, JB Saba, C Lahoud, L Saab, M Haouili, ... Journal of family medicine and primary care 9 (8), 3921-3932, 2020 | 58 | 2020 |
| Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection M Shatila, AS Thomas Journal of Clinical Medicine 11 (17), 5086, 2022 | 25 | 2022 |
| Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases A Pizuorno Machado, M Shatila, C Liu, J Wang, M Altan, HC Zhang, ... Journal of cancer research and clinical oncology 149 (9), 6341-6350, 2023 | 16 | 2023 |
| IL12/23 blockade for refractory immune-mediated colitis: 2 center experience A Thomas, SE Lee, M Shatila, E De Toni, HP Török, NB Khaled, N Powell, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 8 | 2022 |
| Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effects C Liu, R Amin, M Shatila, N Short, M Altan, A Shah, O Alhalabi, ... Journal of cancer research and clinical oncology 149 (7), 3965-3976, 2023 | 5 | 2023 |
| First-line treatment of fecal microbiota transplantation for immune-mediated colitis. Y Wang, K Varatharajalu, M Shatila, MT Campbell, P Msaouel, CA Kovitz Journal of Clinical Oncology 41 (16_suppl), 2510-2510, 2023 | 4 | 2023 |
| Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors K Panneerselvam, D Szafron, RN Amin, D Wei, D Tan, M Altan, ... Annals of Gastroenterology 35 (5), 522, 2022 | 4 | 2022 |
| Tu1734 RANDOMIZED CLINICAL TRIAL OF INFLIXIMAB VERSUS VEDOLIZUMAB FOR IMMUNE CHECKPOINT INHIBITOR RELATED COLITIS Y Wang, K Varatharajalu, M Shatila, AS Thomas, K Junek, N Silva, ... Gastroenterology 164 (6), S-1101, 2023 | 3 | 2023 |
| The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review AP Machado, H Ratliff, A Abdelwahab, MH Vohra, A Kuang, M Shatila, ... Journal of Cancer 14 (16), 2956, 2023 | 3 | 2023 |
| Endoscopy for the diagnosis and treatment of gastrointestinal bleeding caused by malignancy H Abu‐Sbeih, D Szafron, AA Elkafrawy, V Garcia‐Rodriguez, W Ma, A Xu, ... Journal of Gastroenterology and Hepatology 37 (10), 1983-1990, 2022 | 3 | 2022 |
| Single cell RNA sequencing: A new frontier in pancreatic ductal adenocarcinoma M Bou Zerdan, M Shatila, D Sarwal, Y Bouferraa, M Bou Zerdan, S Allam, ... Cancers 14 (19), 4589, 2022 | 3 | 2022 |
| Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia? SA El Hayek, MA Shatila, JA Adnan, LE Geagea, F Kobeissy, FR Talih Expert review of neurotherapeutics 22 (9), 737-749, 2022 | 3 | 2022 |
| Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors G Sperling, M Shatila, K Varatharajalu, Y Lu, M Altan, Y Zhou, D Zhao, ... Journal of cancer research and clinical oncology 149 (19), 17597-17605, 2023 | 2 | 2023 |
| Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicity M Shatila, W Ma, Y Cui, S Naz, A S. Thomas, E N. De Toni, HP Török, ... Journal of cancer research and clinical oncology 149 (10), 7793-7803, 2023 | 2 | 2023 |
| Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patients A Mathew, M Shatila, Z Lai, D Tan, ICG Oliva, J Wang, O Alhalabi, ... Journal of cancer research and clinical oncology 149 (8), 4591-4599, 2023 | 2 | 2023 |
| Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors AR Thomas, C Liu, YT Tong, D Tan, M Altan, BA Siddiqui, M Shatila, ... Journal of cancer research and clinical oncology 149 (8), 5429-5436, 2023 | 2 | 2023 |
| Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis M Kono, M Shatila, G Xu, Y Lu, A Mathew, W Mohajir, K Varatharajalu, ... Cancers 15 (8), 2329, 2023 | 2 | 2023 |
| Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies AR Thomas, M Eyada, M Kono, K Varatharajalu, Y Lu, G Xu, ... Journal of cancer research and clinical oncology 149 (8), 4805-4816, 2023 | 1 | 2023 |
| Effect of fecal transplantation on patients’ reported outcome after immune checkpoint inhibitor colitis. Y Wang, K Varatharajalu, M Shatila, SE Shen, M Herrera, E Gonzalez, ... Journal of Clinical Oncology 41 (16_suppl), 2645-2645, 2023 | 1 | 2023 |
| safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor‐induced colitis. S Hanauer, Y Wang, M Shatila Alimentary Pharmacology & Therapeutics 57 (1), 2023 | 1 | 2023 |
